Showing results (1-10 of 20) with videos related to
Sort By:
Pageof 2
CNS Drugs|January 23, 2013
Cholecystokinin and psychiatric disorders : role in aetiology and potential of receptor antagonists in therapyJ Shlik, E Vasar, J BradwejnNordic Journal of Psychiatry|February 6, 2002
Course of depression: findings from cross-sectional survey in rural UdmurtiaS Pakriev, J Shlik, V VasarPeptides|August 13, 1998
Decrease in short-term memory function induced by CCK-4 in healthy volunteersJ Shlik, D Koszycki, J BradwejnMolecular Psychiatry|January 6, 2010
Advances in molecular genetics of panic disorderE Maron, J M Hettema, J ShlikJournal of Clinical Psychopharmacology|December 6, 2000
A double-blind, placebo-controlled study on the effects of Gotu Kola (Centella asiatica) on acoustic startle response in healthy subjectsJ Bradwejn, Y Zhou, D Koszycki, et al.Journal of Psychopharmacology (Oxford, England)|June 20, 2008
Effects of bupropion augmentation on pro-inflammatory cytokines in escitalopram-resistant patients with major depressive disorderT Eller, V Vasar, J Shlik, et al.Alcohol and Alcoholism (Oxford, Oxfordshire)|June 19, 1998
Prevalence of ICD-10 harmful use of alcohol and alcohol dependence among the rural population in UdmurtiaS Pakriev, V Vasar, A Aluoja, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 15, 2002
The ventilatory response to cholecystokinin tetrapeptide in healthy volunteersM A Katzman, J Duffin, J Shlik, et al.Acta Psychiatrica Scandinavica|June 13, 1998
Prevalence of mood disorders in the rural population of UdmurtiaS Pakriev, V Vasar, A Aluoja, et al.Pharmacopsychiatry|October 23, 2003
Acute effects of cholecystokinin tetrapeptide on brain stem auditory evoked potentials in healthy volunteersT Gunnarsson, C Mahoney, J Shlik, et al.Pageof 2